What is asthma?
Asthma is a long-term disease that affects your airways. It occurs when your airways become swollen and inflamed. Swelling is a reaction to things that you are allergic to or find irritating. When the airways react, they get narrower and less air flows through to your lungs. Cells in the lungs produce extra mucus, further narrowing your airways. This makes breathing hard and causes wheezing. This is called an asthma attack. Attacks are also called flare-ups, exacerbations or episodes. Asthma can be controlled so that you have fewer symptoms. Controlling it means taking medicines as directed by your caregiver and staying away from things that bother your airways, such as cigarette smoke. With treatment, asthma can be managed so you are able to live a normal life.
Asthma Clinical Research Trials
D5896C00027: A 26 Week, Randomized, Double-blind, Parallel-group, Active Controlled, Multicenter, Multinational Safety Study Evaluating the Risk of Serious Asthma-related Events During Treatment With Symbicort®, a Fixed Combination of Inhaled Corticosteroid (ICS) (Budesonide) and a Long Acting ?2-agonist (LABA) (Formoterol) as Compared to Treatment With ICS (Budesonide) Alone in Adult and Adolescent (?12 Years of Age) Patients With Asthma. Participation could last up to 6 months.
Purpose: The purpose of the study is to evaluate the safety of Symbicort compared to inhaled corticosteroid alone during 6 months in adult and adolescent patients with asthma. Participation could last up to 27 weeks.
|For All Studies:
Qualified participants will receive study-related care, study-related exams and study-related medication at no cost. Participants may be compensated for their time and travel.
If you are interested in participating in a study or would like more information, register now or contact The Lung Research Center at 314-439-LUNG (5864) or email: firstname.lastname@example.org.